PARIS, July 17, 2011 /PRNewswire-USNewswire/ -- As the Alzheimer's field
moves closer to new and earlier tests for the disease, innovative global
research initiatives are taking the first important steps to standardize
Alzheimer's biomarkers, as evidenced by two presentations made today at the
A